| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.12.25 | Integrum AB: Integrum's rights issue oversubscribed | 125 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") announced on October 16, 2025 that the Board of Directors had resolved to carry out an issue of shares of series B with preferential right for existing... ► Artikel lesen | |
| 21.11.25 | Integrum AB Q2 Loss Narrows | 1 | RTTNews | ||
| 21.11.25 | Integrum AB: Integrum publishes Interim Report for Q2 2025/26 | 123 | GlobeNewswire (Europe) | Second Quarter 2025/26 (August - October)
Net sales amounted to SEK 22.3 (21.8) million.
Operating result totalled SEK -11.1 (-11.3) million.
Profit/loss after tax amounted to SEK -7.4 (-8.9)... ► Artikel lesen | |
| 19.11.25 | Integrum AB: Invitation to the Second Quarter 2025/26 Results Presentation | 1 | Cision News | ||
| 19.11.25 | True gibt neue Investitionspartnerschaft mit Integrum bekannt, um die Zukunft der Führungskräftevermittlung neu zu definieren | 270 | Business Wire | True, die weltweit führende Plattform für Führungskräfte, die die technologische Entwicklung der Branche durch Daten, KI und Fachwissen vorantreibt, hat heute eine neue strategische Investitionspartnerschaft... ► Artikel lesen | |
| 18.11.25 | INTEGRUM AB: The subscription period in Integrum's rights issue has begun | 1 | Cision News | ||
| INTEGRUM Aktie jetzt für 0€ handeln | |||||
| 13.11.25 | Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26 | 157 | GlobeNewswire (Europe) | Mölndal, 13 November 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), today publishes, in connection with the ongoing rights issue, preliminary and unaudited financial key figures... ► Artikel lesen | |
| 11.11.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.11.2025 | 388 | Xetra Newsboard | Das Instrument TE5 SE0009806045 TERRANET AB B EQUITY wird ex Kapitalmassnahme gehandelt am 11.11.2025 The instrument TE5 SE0009806045 TERRANET AB B EQUITY is traded ex capital adjustment on 11.11.2025Das... ► Artikel lesen | |
| 10.11.25 | Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs | 141 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") has today entered into an agreement for a bridge loan of up to SEK 7 million with Buntel AB. The purpose of the loan is to cover the Company's short-term... ► Artikel lesen | |
| 23.10.25 | Integrum AB: Integrum announces organizational restructuring to strengthen its commercial focus | 193 | GlobeNewswire (Europe) | Mölndal, Sweden, October 23, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announced a strategic organizational restructuring to accelerate the commercialization of OPRA... ► Artikel lesen | |
| 20.10.25 | Integrum AB: Integrum announces that the Swedish Securities Council has published a statement regarding the takeover offer for Integrum | 177 | GlobeNewswire (Europe) | Mölndal, Sweden, October 20, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) notes that, in statement 2025:45 dated October 17, 2025, the Swedish Securities Council (Aktiemarknadsnämnden)... ► Artikel lesen | |
| 16.10.25 | Integrum: $2.5 Billion Fund II Closed, Bringing Total Assets To $5 Billion | 2 | pulse2.com | ||
| 16.10.25 | Integrum AB: Integrum provides operational update ahead of Q2 report | 125 | GlobeNewswire (Europe) | Mölndal, Sweden, October 16, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today provides an operational update. Following the recent non-completed bid process, Integrum is taking... ► Artikel lesen | |
| 16.10.25 | Integrum AB: Integrum resolves on a rights issue of shares of series B of approximately SEK 42.6 million subject to approval by extraordinary general meeting and earlier release of Q2 report | 223 | GlobeNewswire (Europe) | The Board of Directors of Integrum AB (publ) ("Integrum" or the "Company") has today resolved to carry out a share issue of approximately SEK 42.6 million before deduction of issue costs with preferential... ► Artikel lesen | |
| 01.10.25 | Duke Capital - Follow-On Investment into Integrum Group Holdings | 4 | RNS | ||
| 25.09.25 | The observation status for Integrum AB is removed | 211 | GlobeNewswire | On July 22, 2025, the shares in Integrum AB (the "Company") were given observation status with reference to a public takeover offer from OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a... ► Artikel lesen | |
| 18.09.25 | INTEGRUM AB: Integrum provides update on OsteoCentric's public offer and provides correction of previous announced information | 4 | Cision News | ||
| 17.09.25 | INTEGRUM AB: Integrum comments on OsteoCentric's announcement of outcome in the public offer | 1 | Cision News | ||
| 16.09.25 | OSTEOCENTRIC ONCOLOGY AND BONE ANCHORED PROSTHESES LLC: FINAL OUTCOME FOR THEIC OFFER BY OSTEOCENTRIC TO THE SHAREHOLDERS OF INTEGRUM: OSTEOCENTRIC DOES NOT COMPLETE THE OFFER | 3 | Cision News | ||
| 04.09.25 | INTEGRUM AB: Integrum Unveils Global Marketing Strategy at AOPA National Assembly | 1 | Cision News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 87,83 | +0,83 % | Medtronic plc: Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances | GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice... ► Artikel lesen | |
| INTUITIVE SURGICAL | 425,95 | +1,12 % | Amphenol, Intuitive Surgical, Fanuc und Co - Robotik boomt! | Robotik hat sich zu einer Schlüsseltechnologie der globalen Wirtschaft entwickelt. In zahlreichen Anwendungsfeldern steigern Roboter die Effizienz, stabilisieren Lieferketten und beschleunigen Prozesse.... ► Artikel lesen | |
| THERMO FISHER | 490,95 | -0,53 % | Thermo Fisher Scientific Earnings Up In Q4 | WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO), a life sciences and clinical research company, on Thursday reported that net income increased in the fourth quarter compared with... ► Artikel lesen | |
| STRATEC | 21,800 | -0,91 % | Stratec: Experten rechnen mit konservativem Ausblick | Das vierte Quartal 2024 war bei Stratec besonders stark. Dieses Niveau dürfte die Gesellschaft Ende 2025 nicht erreicht haben. So rechnen die Analysten der Deutschen Bank auch mit einem Minus von 5... ► Artikel lesen | |
| HIMS & HERS HEALTH | 22,790 | +1,65 % | Hims & Hers uses another Super Bowl ad to tackle healthcare affordability | ||
| EUROFINS SCIENTIFIC | 67,76 | 0,00 % | Eurofins Scientific SE: Weekly Report on Share Repurchases from 26th January to 30th January 2026 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument ... ► Artikel lesen | |
| BECTON DICKINSON | 170,00 | -0,82 % | BD (Becton, Dickinson and Company): BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26 | FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology... ► Artikel lesen | |
| FAMICORD | 5,250 | -0,94 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,770 | +1,84 % | Geratherm Medical wechselt vom Börsensegment Scale in den Open Market | Die Geratherm Medical AG beendet zum 27. April 2026 die Einbeziehung ihrer Aktien in das Börsensegment Scale der Frankfurter Wertpapierbörse und wechselt ins Basic Board am Open Market. Die Börsennotierung... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 77,40 | -0,77 % | Boston Scientific Stock: Analyst Estimates & Ratings | ||
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| PAUL HARTMANN | 221,00 | +2,79 % | Vorläufiges Jahresergebnis 2025: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - Die HARTMANN GRUPPE hat im Geschäftsjahr 2025 ein vorläufiges organisches Umsatzwachstum von 2,2 % erzielt.Das vorläufige bereinigte EBITDA liegt mit 277 Mio. EUR um rund 15 Mio.... ► Artikel lesen | |
| RESMED | 216,90 | +0,42 % | Resmed Inc Q2 Profit Advances | WASHINGTON (dpa-AFX) - Resmed Inc (RMD.AX) released earnings for its second quarter that Increases, from last yearThe company's earnings totaled $392.59 million, or $2.68 per share. This compares... ► Artikel lesen | |
| MCKESSON | 720,20 | +0,33 % | McKesson Corporation Completes Divestiture of Norwegian Operations | McKesson Corporation (NYSE: MCK) announced today that it has closed the transaction to sell its retail and distribution businesses in Norway to NorgesGruppen, a privately owned retail group.
McKesson... ► Artikel lesen | |
| INMODE | 14,020 | -0,57 % | InMode gains as it evaluates strategic alternatives |